Evidence map›Paper›PMID 35909954›Full record

ArticleFrontiers in cellular and infection microbiology2022

Characterization and Comparative Genomic Analysis of a Highly Colistin-Resistant

Mahendra Gaur, Suchanda Dey, Anshuman Sahu, Sangita Dixit, S Sarathbabu, John Zothanzama, Rajesh Kumar Sahoo, Dibyajyoti Uttameswar Behera, Monika, Enketeswara Subudhi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mahendra GaurDepartment of Biotechnology, Punjabi University, Patiala, India.
Suchanda DeyCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
Anshuman SahuCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
Sangita DixitCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
S SarathbabuDepartment of Biotechnology, Mizoram University, Aizawl, India.
John ZothanzamaDepartment of Biotechnology, Mizoram University, Aizawl, India.
Rajesh Kumar SahooCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
Dibyajyoti Uttameswar BeheraCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
MonikaDepartment of Biotechnology, Mata Gujri College (Autonomous), Fatehgarh Sahib, India.
Enketeswara SubudhiCentre for Biotechnology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
Siksha O Anusandhan University · INMizoram University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the first time, we describe the whole genome of a yellow-pigmented, capsule-producing, pathogenic, and colistin-resistant

Indexed as

Anti-Bacterial AgentsChryseobacteriumColistinDrug Resistance, Multiple, BacterialFlavobacteriaceae InfectionsRNA, Ribosomal, 16Sbeta-LactamasesGenome, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesColistinRNA, Ribosomal, 16Scapsular polysaccharide (CPS)Chryseobacterium gallinarumcolistin-resistantcomparative genomicsuncommon pathogenα-hemolysisβ-lactamases

Identifiers

PMID35909954
PMCPMC9329510
OpenAlexW4285387627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.